Furthermore, TIGIT and TIM-3 IC molecules are significantly up-regulated on NK cells in HBV-HCC patients, accompanied by substantial impairments in cytotoxic activity and cytokine production capacity [154]. Here, TIGIT is linked to hepatocellular carcinoma.